Loading chat...
MN SF3154
Bill
Status
2/14/2022
Primary Sponsor
David Dibble
Click for details
AI Summary
-
Authorizes pharmacists to prescribe, dispense, and administer FDA-approved antiretroviral drugs for HIV prevention (preexposure and postexposure prophylaxis) if they meet requirements established by the board of pharmacy
-
Requires the board of pharmacy to develop a standardized protocol for HIV prevention drug prescribing by January 1, 2023, and mandates pharmacists complete approved training programs before prescribing
-
Permits pharmacists to order, conduct, and interpret laboratory tests necessary for HIV prevention therapies if they meet board-established requirements
-
Prohibits health plans from using step therapy protocols or requiring prior authorization for medically necessary antiretroviral drugs for HIV prevention
-
Requires health plans to provide equal coverage terms, reimbursement rates, and network access for HIV prevention drugs prescribed by qualified pharmacists as for drugs prescribed by physicians, physician assistants, or advanced practice registered nurses
Legislative Description
Pharmacist authorization to prescribe, dispense and administer drugs to prevent the acquisition of human immunodeficiency virus establishment; pharmacist authorization to order, conduct, and interpret laboratory tests necessary for therapy that uses drugs to prevent the acquisition of human immunodeficiency virus establishment
Last Action
Author added Duckworth
3/28/2022